Get the Stockscreener App
0.4782
1.73%
-0.0084
After Hours:
.48
0.0018
+0.38%
Turnstone Biologics Corp Stock (TSBX) Forecast
The Turnstone Biologics Corp (TSBX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.8629, representing a +1,753% increase from the current price of $0.4782. The highest analyst price target is $8.6491, and the lowest is $9.0767.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TSBX Price Target
Average 7.9713
(+1,567% Upside)
Is Turnstone Biologics Corp (TSBX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.37 | Neutral |
| STOCH(9,6) | 38.55 | Neutral |
| STOCHRSI(14) | 89.94 | Sell |
| MACD(12,26) | -0.0074 | Buy |
| ADX(14) | 14.58 | Neutral |
| William %R | -42.55 | Neutral |
| CCI(14) | 42.51 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4616
Buy
|
0.4622
Buy
|
| MA20 |
0.4607
Buy
|
0.4664
Buy
|
| MA50 |
0.4846
Sell
|
0.4984
Sell
|
| MA100 |
0.5043
Sell
|
0.6933
Sell
|
| MA200 |
1.3783
Sell
|
1.1727
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TSBX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TSBX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 51.37 indicates that TSBX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.55 indicates that TSBX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 89.94 indicates that TSBX is oversold. This suggests that TSBX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.58 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 42.51 indicates that TSBX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TSBX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Turnstone Biologics Corp financial reports and earnings history, Turnstone Biologics Corp (TSBX) stock could reach $35.33 by 2030, $92.63 by 2040 and $144.15 by 2050. See the projected annual prices until 2050 of the Turnstone Biologics Corp stock below:
- Turnstone Biologics Corp (TSBX) is expected to reach an average price of $89.10 in 2035, with a high prediction of $88.67 and a low estimate of $25.19. This indicates an $18,532% rise from the last recorded price of $0.4782.
- Turnstone Biologics Corp (TSBX) stock is projected to chart a bullish course in 2040, with an average price target of $86.25, representing an $17,936% surge from its current level. The forecast ranges from a conservative $86.31 to a sky-high $92.63.
- Our analysts predict Turnstone Biologics Corp (TSBX) to jump 36,658% by 2045, soaring from $50.91 to an average price of $175.78, potentially reaching $173.83. While $50.91 is the low estimate, the potential upside is significant.
- Turnstone Biologics Corp (TSBX) stock is expected to climb by 2050, reaching an average of $132.27, a $27,560% jump from its current level. However, a wide range of estimates exists, with high and low targets of $144.15 and $133.05, respectively, highlighting the market's uncertainty.
Turnstone Biologics Corp Stock (TSBX) Year by Year Forecast
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2025
Turnstone Biologics Corp Stock (TSBX) is expected to reach an average price of $7.2906 in 2025, with a high prediction of $14.50 and a low estimate of $0.0855. This indicates an +1,425% rise from the last recorded price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $9.1434 | $9.0767 | $8.6491 | +1,812% |
| April, 2025 | $7.1612 | $8.14 | $8.6689 | +1,398% |
| May, 2025 | $7.4534 | $7.5434 | $7.6478 | +1,459% |
| June, 2025 | $6.2756 | $6.37 | $6.8591 | +1,212% |
| July, 2025 | $5.0484 | $5.1679 | $6.0268 | +955.72% |
| August, 2025 | $1.9757 | $3.129 | $4.649 | +313.15% |
| September, 2025 | $2.6079 | $1.7812 | $2.0024 | +445.36% |
| October, 2025 | $1.6657 | $1.8657 | $2.1935 | +248.33% |
| November, 2025 | $14.96 | $1.4468 | $10.08 | +3,028% |
| December, 2025 | $14.99 | $15.28 | $14.50 | +3,035% |
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2026
The predicted value for Turnstone Biologics Corp (TSBX) in 2026 is set at an average of $11.95. Estimates vary from a peak of $20.47 to a trough of $3.4253, indicating an +2,399% surge from the present price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.27 | $13.64 | $14.40 | +2,885% |
| February, 2026 | $12.62 | $12.69 | $12.56 | +2,538% |
| March, 2026 | $10.78 | $10.81 | $11.53 | +2,153% |
| April, 2026 | $8.9318 | $9.0218 | $10.14 | +1,768% |
| May, 2026 | $6.7052 | $7.97 | $8.3602 | +1,302% |
| June, 2026 | $5.4285 | $4.9319 | $4.9185 | +1,035% |
| July, 2026 | $4.3702 | $4.4119 | $4.8752 | +813.90% |
| August, 2026 | $17.05 | $3.4253 | $16.63 | +3,465% |
| September, 2026 | $20.81 | $21.41 | $20.47 | +4,251% |
| October, 2026 | $18.76 | $19.13 | $20.34 | +3,823% |
| November, 2026 | $17.92 | $17.97 | $18.19 | +3,648% |
| December, 2026 | $15.22 | $15.25 | $17.47 | +3,082% |
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Turnstone Biologics Corp (TSBX) is $16.10, with a high forecast of $26.79 and a low forecast of $5.4037. This indicates an +3,266% increase from the last price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.13 | $13.91 | $14.46 | +2,647% |
| February, 2027 | $11.44 | $12.01 | $12.43 | +2,292% |
| March, 2027 | $8.3447 | $8.0825 | $10.06 | +1,645% |
| April, 2027 | $6.5992 | $6.8592 | $7.557 | +1,280% |
| May, 2027 | $5.782 | $5.4037 | $6.1603 | +1,109% |
| June, 2027 | $28.07 | $23.72 | $26.79 | +5,769% |
| July, 2027 | $24.50 | $25.94 | $26.19 | +5,024% |
| August, 2027 | $23.15 | $23.35 | $23.82 | +4,740% |
| September, 2027 | $19.80 | $20.64 | $22.43 | +4,040% |
| October, 2027 | $18.52 | $18.64 | $18.92 | +3,773% |
| November, 2027 | $15.94 | $16.02 | $16.49 | +3,233% |
| December, 2027 | $12.01 | $11.23 | $14.94 | +2,411% |
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2028
In 2028, Turnstone Biologics Corp (TSBX) is projected to reach an average price of $23.40, with a high projection of $39.42 and a low estimate of $7.3821. This indicates an +4,793% rise from the last price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.6126 | $10.17 | $10.75 | +1,910% |
| February, 2028 | $7.8782 | $8.0182 | $8.4904 | +1,547% |
| March, 2028 | $33.25 | $7.3821 | $33.10 | +6,853% |
| April, 2028 | $32.39 | $32.50 | $32.56 | +6,673% |
| May, 2028 | $28.29 | $28.49 | $29.98 | +5,816% |
| June, 2028 | $25.82 | $26.04 | $27.46 | +5,299% |
| July, 2028 | $23.16 | $23.22 | $24.27 | +4,744% |
| August, 2028 | $19.56 | $19.64 | $22.38 | +3,990% |
| September, 2028 | $14.28 | $14.38 | $18.44 | +2,887% |
| October, 2028 | $13.47 | $13.54 | $13.67 | +2,717% |
| November, 2028 | $9.9739 | $10.11 | $11.90 | +1,986% |
| December, 2028 | $40.63 | $9.3605 | $39.42 | +8,396% |
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2029
The 2029 price forecast for Turnstone Biologics Corp Stock (TSBX) is $28.54 on average, with a high prediction of $45.73 and a low estimate of $11.34. This represents an +5,868% increase from the previous price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $38.12 | $38.23 | $38.89 | +7,871% |
| February, 2029 | $33.46 | $35.20 | $35.60 | +6,898% |
| March, 2029 | $31.41 | $31.50 | $32.48 | +6,469% |
| April, 2029 | $27.89 | $28.04 | $30.23 | +5,732% |
| May, 2029 | $23.73 | $24.00 | $26.89 | +4,863% |
| June, 2029 | $18.31 | $19.47 | $22.75 | +3,730% |
| July, 2029 | $16.60 | $16.86 | $17.08 | +3,372% |
| August, 2029 | $12.73 | $12.93 | $15.60 | +2,562% |
| September, 2029 | $47.12 | $11.34 | $42.83 | +9,754% |
| October, 2029 | $44.22 | $44.64 | $45.73 | +9,148% |
| November, 2029 | $41.16 | $41.11 | $43.05 | +8,508% |
| December, 2029 | $37.16 | $37.23 | $38.48 | +7,671% |
Turnstone Biologics Corp Stock (TSBX) Price Forecast for 2030
Turnstone Biologics Corp Stock (TSBX) is expected to reach an average price of $32.68 in 2030, with a high forecast of $52.05 and a low forecast of $13.32. This signifies an +6,735% surge from the last price of $0.4782.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $32.21 | $32.36 | $35.33 | +6,636% |
| February, 2030 | $28.20 | $28.29 | $31.09 | +5,797% |
| March, 2030 | $23.63 | $24.90 | $27.04 | +4,842% |
| April, 2030 | $20.01 | $20.56 | $20.39 | +4,084% |
| May, 2030 | $16.02 | $16.08 | $18.66 | +3,250% |
| June, 2030 | $49.80 | $13.32 | $49.38 | +10,314% |
| July, 2030 | $50.63 | $51.23 | $52.05 | +10,487% |
| August, 2030 | $46.24 | $46.61 | $49.58 | +9,569% |
| September, 2030 | $43.06 | $43.11 | $45.08 | +8,904% |
| October, 2030 | $37.42 | $37.45 | $42.01 | +7,724% |
| November, 2030 | $32.99 | $33.77 | $36.08 | +6,799% |
| December, 2030 | $28.95 | $29.52 | $31.70 | +5,954% |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):